Members

PGRN Research Members, 2015-present

Russ B. Altman, M.D., Ph.D., Stanford University and Teri Klein, Ph.D.,   Pharmacogenomics Knowledge Base (PharmGKB)
Kathleen M. Giacomini, Ph.D. and Graham T. Johnson, Ph.D., University of California, San Francisco PGRN Hub
Ronald M. Krauss, M.D., Children's Hospital Oakland Research Institute, California and Aldons "Jake" Lusis, Ph.D., University of California, Los Angeles Pharmacogenomics of Statin Therapy
Mary V. Relling, Pharm.D., St. Jude Children's Research Hospital, Memphis, Tennessee and Mignon Lee-Cheun Loh, M.D., University of California, San Francisco Center for Precision Medicine in Leukemia
Mary V. Relling, Pharm.D., St. Jude Children's Research Hospital, Memphis, Tennessee and Teri E. Klein, Ph.D., Stanford University Clinical Pharmacogenetics Implementation Consortium (CPIC)
Allan Rettie, Ph.D. and Douglas M. Fowler, Ph.D., University of Washington F-CAP: Functionalization of Variants in Clinically Actionable Pharmacogenes
Dan M. Roden, M.D., Joshua C. Denny, M.D., M.S., and Elizabeth J. Phillips, M.D., Vanderbilt University Medical Center, Nashville, Tennessee Improving Prediction of Drug Action

Alumni

Christopher G. Chute, M.D., Dr. P.H.
Mayo Clinic, Rochester, Minn.		 PGRN Ontology Network Resource (PHONT) Link to external Web site
David A. Flockhart, M.D., Ph.D.
Indiana University, School of Medicine		 Consortium on Breast Cancer Pharmacogenomics (COBRA) Link to external Web site
Kathleen M. Giacomini, Ph.D.
University of California, San Francisco		 Pharmacogenetics of Membrane Transporters (PMT) Link to external Web site
Kathleen M. Giacomini, Ph.D.
University of California, San Francisco		 Pharmacogenomics Research Network III and RIKEN Center for Genomic Medicine Alliance (PGRN-CGM) Link to external Web site
Richard A. Gibbs, Ph.D.
Baylor College of Medicine, Houston		 Next Gen Sequencing-Baylor/Mayo (BCM-HGSC) Link to external Web site
Julie A. Johnson, Pharm.D. and Rhonda Cooper-DeHoff, Pharm.D.
University of Florida, Gainesville		 Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Link to external Web site
John Kelsoe, M.D.
University of California, San Diego		 Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Ronald M. Krauss, M.D.
Children's Hospital Oakland Research Institute, California		 Pharmacogenomics and Risk of Cardiovascular Disease (PARC) Link to external Web site
Caryn Lerman, Ph.D., University of Pennsylvania, Philadelphia and Rachel F. Tyndale, Ph.D., University of Toronto Pharmacogenetics of Nicotine Addiction Treatment (PNAT) Link to external Web site
Julio Licinio, M.D.
University of Miami, Miller School of Medicine		 University of Miami Pharmacogenetics and Pharmacogenomics Research Group (PPRG)
Elaine R. Mardis, Ph.D.
The Genome Center, Washington University School of Medicine		 Pharmacogenomics Research Network - Next Generation Sequencing (WU-NGS) Link to external Web site
Howard L. McLeod, Pharm.D.
University of North Carolina at Chapel Hill		 Functional Polymorphism Analysis in Drug Pathways (CREATE)
Prakash M. Nadkarni, M.D.
Yale University, New Haven, Connecticut		 Design and Implementation of Pharmacogenetic Network (DIPN)
Deborah A. Nickerson, Ph.D.
University of Washington School of Medicine, Seattle		 PGRN Network Resource: Next Generation Sequencing (UW-NEXTGEN) Link to external Web site
Daniel T. O'Connor, M.D.
University of California, San Diego		 Autonomic Pharmacodynamic Pharmacogenomics
Soumya Raychaudhuri, M.D., Ph.D. and Michael Brenner, M.D.
Brigham and Women's Hospital, Boston		 Pharmacogenomics of Rheumatoid Arthritis Therapy (PhRAT) Link to external Web site
Mark J. Ratain, M.D., Nancy J. Cox, Ph.D. and M. Eileen Dolan, Ph.D.
University of Chicago		 Pharmacogenetics of Anticancer Agents (PAAR) Link to external Web site
Mary V. Relling, Pharm.D.
St. Jude Children's Research Hospital, Memphis, Tennessee		 Pharmacogenomics of Anticancer Agents Research in Children (PAAR4Kids) Link to external Web site
Marylyn D. Ritchie, Ph.D.
Vanderbilt University, Nashville, Tennessee		 PGRN Statistical Analysis Resource (P-STAR) Link to external Web site
Dan M. Roden, M.D.
Vanderbilt University, Nashville, Tennessee		 PharmacoGenomic discovery and replication in very large patient POPulations (PG-POP) Link to external Web site
Dan M. Roden, M.D.
Vanderbilt University Medical Center, Nashville, Tennessee		 Pharmacogenomics of Arrhythmia Therapy (PAT) Link to external Web site
Mark A. Rothstein, J.D.
University of Louisville, Kentucky		 Pharmacogenomics & Minority Populations (PMP)
Wolfgang Sadee, Dr.rer.nat., M. Pharmacy
The Ohio State University, Columbus		 Expression Genetics in Drug Therapy (XGEN) Link to external Web site
Alan R. Shuldiner, M.D.
University of Maryland School of Medicine, Baltimore		 The Amish Pharmacogenomics of Anti-Platelet Intervention Study (PAPI) Link to external Web site
Kenneth E. Thummel, Ph.D. and Wylie Burke, M.D., Ph.D.
University of Washington, Seattle		 Pharmacogenetics in Rural and Underserved Populations (NWAP) Link to external Web site
Richard Weinshilboum, M.D. and Liewei Wang, M.D., Ph.D.
Mayo Clinic, Rochester, Minn.		 Pharmacogenetics of Phase II Drug Metabolizing Enzymes (PPII)
Scott T. Weiss, M.D., M.S. and Kelan G. Tantisira, M.D., M.P.H.
Brigham and Women's Hospital and Harvard Medical School, Boston		 Pharmacogenetics of Asthma Treatment (PHAT) Link to external Web site
​